Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis-related fatigue.

William S MacAllister1, Lauren B Krupp

  • 1National Pediatric Multiple Sclerosis Center, State University of New York at Stony Brook, Stony Brook, NY 11794-8121, USA.

Physical Medicine and Rehabilitation Clinics of North America
|May 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance validity tests in a large racially and linguistically diverse pediatric and young adult clinical sample: Investigations of the TOMM, MVP, and MSVT.

The Clinical neuropsychologist·2026
Same author

Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases.

JAMA neurology·2026
Same author

Childhood adversity, allostatic load and epigenetic signatures in paediatric and adult-onset multiple sclerosis.

Brain communications·2026
Same author

Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years.

Neurology·2025
Same author

Smouldering disease in paediatric-onset multiple sclerosis.

EBioMedicine·2025
Same author

Relation of Visual Function, Retinal Thickness by Optical Coherence Tomography, and MRI Brain Volume in Pediatric-Onset Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same journal

Preface.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Pain Unbound: A Comprehensive Review.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Dual Frontiers Cancer and Palliative Care.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Pain Management Across Special Populations: Pediatrics, Geriatrics, and Pregnancy.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Healing from Within: Regenerative Medicine in Pain Therapy.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

The Brain in Pain: Exploring Central Pain Disorders.

Physical medicine and rehabilitation clinics of North America·2026
See all related articles

Fatigue significantly impacts multiple sclerosis (MS) patients

Area of Science:

  • Neurology
  • Immunology
  • Neuroscience

Background:

  • Fatigue is the most prevalent symptom in multiple sclerosis (MS), profoundly affecting daily life, social interactions, and occupational functioning.
  • The pathophysiology of MS fatigue is complex and multifactorial, involving immune dysregulation, central nervous system changes, neuroendocrine alterations, and contributing factors like deconditioning, sleep issues, pain, and medication side effects.
  • Accurate assessment of MS fatigue is crucial for guiding treatment strategies in both clinical practice and research.

Purpose of the Study:

  • To review the current understanding of fatigue in multiple sclerosis (MS).
  • To explore the pathophysiological underpinnings of MS-related fatigue.
  • To summarize available assessment tools and treatment strategies for managing MS fatigue.

Related Experiment Videos

Main Methods:

  • Literature review of studies on fatigue in multiple sclerosis (MS).
  • Analysis of pathophysiological mechanisms contributing to MS fatigue.
  • Evaluation of nonpharmacologic and pharmacologic interventions for MS fatigue.

Main Results:

  • MS fatigue is linked to quality of life and mood.
  • Nonpharmacologic interventions like exercise, cooling, and energy conservation are primary treatment steps.
  • Pharmacologic agents, including amantadine, modafinil, pemoline, and antidepressants, can effectively reduce MS fatigue, though not FDA-approved specifically for this indication.

Conclusions:

  • Effective management of MS fatigue requires a comprehensive approach, addressing its multifactorial nature.
  • Nonpharmacologic strategies should be prioritized as the first line of treatment for MS fatigue.
  • Pharmacologic interventions offer additional benefits for patients with persistent or severe MS fatigue, improving overall quality of life.